GlucoTrack study backs year-long stability for implantable continuous glucose sensor design

GlucoTrack Inc

GlucoTrack Inc

GCTK

0.00
  • GlucoTrack flagged publication of peer-reviewed research supporting long-life sensor design for its fully implantable continuous blood glucose monitoring system.
  • Results were already presented via an April 7, 2026 publication in IEEE Sensors Journal.
  • Study tracked long-term stability of glucose-sensing enzyme activity in lab conditions, supporting feasibility of extended-use implantable monitors.
  • Work is positioned to strengthen technical evidence package as GlucoTrack advances toward near-term FDA IDE submission.
  • Company also cited previously disclosed first-in-human clinical results that supported performance consistency with no serious safety issues tied to procedure or device.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604210800PRIMZONEFULLFEED9693520) on April 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.